Principal Financial Group Inc. Acquires Shares of 17,352 ZimVie Inc. (NASDAQ:ZIMV)

Principal Financial Group Inc. bought a new position in ZimVie Inc. (NASDAQ:ZIMV) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 17,352 shares of the company’s stock, valued at approximately $275,000. Principal Financial Group Inc. owned about 0.06% of ZimVie as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. American Century Companies Inc. raised its holdings in shares of ZimVie by 212.8% during the second quarter. American Century Companies Inc. now owns 412,434 shares of the company’s stock valued at $7,527,000 after acquiring an additional 280,565 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in ZimVie during the 2nd quarter valued at $3,993,000. Cetera Advisors LLC bought a new position in ZimVie in the 1st quarter worth $2,615,000. Lighthouse Investment Partners LLC purchased a new stake in shares of ZimVie in the 2nd quarter worth about $1,692,000. Finally, Renaissance Technologies LLC boosted its stake in shares of ZimVie by 26.6% during the 2nd quarter. Renaissance Technologies LLC now owns 406,400 shares of the company’s stock valued at $7,417,000 after purchasing an additional 85,300 shares in the last quarter. 95.63% of the stock is owned by hedge funds and other institutional investors.

ZimVie Stock Performance

Shares of ZimVie stock opened at $14.41 on Tuesday. The business has a fifty day simple moving average of $14.83 and a two-hundred day simple moving average of $16.62. The firm has a market capitalization of $397.72 million, a P/E ratio of -1.10 and a beta of 2.14. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a 12 month low of $9.00 and a 12 month high of $22.40.

Analysts Set New Price Targets

Separately, Needham & Company LLC raised their price objective on shares of ZimVie from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Friday, August 2nd.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.